Bottoms up: New insights about rectal infections and HIV/STI prevention
Wednesday, February 3, 2021
•
OA16
•
5:30 PM
>
6:30 PM
•
Bottoms up: New insights about rectal infections and HIV/STI prevention
•
Live channel 2
5:30 PM
•
OA16.01
•
Trends in incidence of bacterial sexually transmitted infections among gay and bisexual men using PrEP in Australia
See abstract
5:38 PM
•
OA16.02
•
For MSM attending sexual health clinics in England, rates of new HIV infections decreased and rates of new rectal GC diagnosis increased between 2010-2018
See abstract
5:46 PM
•
OA16.03
•
Comparing applicator vs. "as lubricant" delivery of rectal dapivirine gel (MTN-033)
See abstract
5:54 PM
•
OA16.04
•
Phase 1 safety and pharmacokinetic study of candidate rectal microbicide PC-1005 rectal gel (MIV-150/zinc acetate /carrageenan) in HIV-1 seronegative adults (MTN-037)
See abstract
6:02 PM
•
OA16.05
•
A randomized, double blind, placebo-controlled, phase 1 safety and pharmacokinetic study of dapivirine gel (0.05%) administered rectally to HIV-1 seronegative adults (MTN-026)
See abstract
6:10 PM
•
OA17.06
•
Live Q&A
See abstract
|